| Date |
Time |
Source |
Heading |
|---|
| 4/25/2024 | 8:52 | IHNW | FeaturedCannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA |
| 2/27/2024 | 10:50 | PRNUS | Kuehn Law Encourages CHRD, AVRO, KAMN, and CTLT Investors to.. |
| 2/23/2024 | 16:00 | EDGAR2 | Form SCHEDULE 13G - Statement of acquisition of beneficial.. |
| 2/05/2024 | 20:01 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 2/05/2024 | 19:59 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 2/05/2024 | 19:57 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 2/05/2024 | 19:56 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 2/01/2024 | 14:25 | PRNUS | Kuehn Law Encourages ICVX, CSTR, AVRO, and CALB Investors to.. |
| 1/30/2024 | 16:47 | EDGAR2 | Form 425 - Prospectuses and communications, business.. |
| 1/30/2024 | 16:07 | EDGAR2 | Form 425 - Prospectuses and communications, business.. |
| 1/30/2024 | 16:05 | EDGAR2 | Form 8-K - Current report |
| 1/30/2024 | 09:05 | EDGAR2 | Form 425 - Prospectuses and communications, business.. |
| 1/30/2024 | 08:39 | EDGAR2 | Form 8-K - Current report |
| 1/30/2024 | 08:00 | BW | AVROBIO and Tectonic Therapeutic Announce Merger |
| 11/09/2023 | 16:30 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 11/03/2023 | 16:15 | EDGAR2 | Form RW - Registration Withdrawal Request |
| 8/10/2023 | 16:32 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 7/12/2023 | 07:13 | EDGAR2 | Form 8-K - Current report |
| 7/12/2023 | 07:00 | BW | AVROBIO to Explore Strategic Alternatives |
| 7/03/2023 | 13:17 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 6/12/2023 | 07:00 | BW | AVROBIO Completes Sale of Cystinosis Gene Therapy Program.. |
| 5/22/2023 | 07:00 | BW | AVROBIO Announces Agreement to Sell Cystinosis Gene Therapy.. |
| 5/18/2023 | 08:14 | DJN | Avrobio Stock Up 16% on Positive Data for Cystinosis.. |
| 5/18/2023 | 07:00 | BW | AVROBIO Announces Positive Data from Phase 1/2 Clinical.. |
| 5/11/2023 | 07:00 | BW | AVROBIO Reports First Quarter 2023 Financial Results and.. |
| 5/01/2023 | 07:30 | BW | AVROBIO Announces Leadership Transition |
Register to chat with like-minded investors on our interactive forums.
